Med Spa Marketing in Canada: What's Actually Different
By the Med Spa Growth Company team
The short answer
Health Canada actively monitors and enforces advertising rules for treatments involving prescription drugs and regulated medical devices — including Botox, neuromodulators, and dermal fillers — under the Food and Drugs Act. Before/after photos and casual mentions of prescription product names in captions are both common places clinics get flagged. This is general information, not legal advice; a voluntary Advertising Preclearance Agency review is worth considering before publishing higher-risk content.
The core of good med spa marketing — clear treatment pages, a strong Google Business Profile, real reviews, structured content AI assistants can cite — works the same in Canada as anywhere else. What's genuinely different is the regulatory layer sitting on top of it, and it's stricter and more actively enforced than a lot of clinics assume.
Health Canada is actively enforcing this, not just publishing guidelines
Health Canada regulates advertising for health products under the Food and Drugs Act and the Controlled Drugs and Substances Act, and it's been increasingly active in the medical aesthetics space specifically — clinics have reported being contacted directly, with websites and social channels monitored for compliance. This isn't a theoretical risk; treat it as a live enforcement environment.
Botox, fillers, and other regulated products need careful handling
Many of the treatments a med spa offers involve prescription drugs (neuromodulators like Botox) or regulated medical devices (dermal fillers, some energy-based devices) — categories that carry some of the strictest advertising rules in the country. Casually naming a prescription product in an Instagram caption, not just in a formal ad, has been flagged as a violation in practice, even when the intent was purely informational.
Before/after photos carry the same core risks as elsewhere, plus product-naming risk
The general before/after principles — real and representative images, documented consent, a clear disclaimer that results vary — still apply. In Canada, the additional risk is pairing that image with language that names or implies a specific prescription product or overstates what it can do, which is where Health Canada's product-advertising rules and general before/after compliance overlap.
Consider a voluntary preclearance review for higher-risk content
Health Canada supports a voluntary system of Advertising Preclearance Agencies (APAs) that review marketing materials before they're published. For content involving prescription drugs or regulated devices, a preclearance review is a genuinely useful way to catch a compliance issue before it's live, rather than after a complaint or inquiry.
Frequently asked questions
Does Health Canada really enforce med spa advertising rules?
Yes — clinics have reported direct outreach and site visits, and social channels are actively monitored. Treat this as a live enforcement environment, not a theoretical one.
Can I mention Botox by name in a social media post?
This is exactly the kind of question worth a preclearance review or a lawyer's input before you publish — casually naming a prescription product has been flagged as a violation even in informational, non-ad content.
Is a voluntary preclearance review worth the cost?
For content involving prescription drugs or regulated devices, it's a reasonable way to catch compliance issues before publishing rather than after — especially given how actively this space is monitored.
Does the marketing strategy itself differ for Canadian med spas?
The fundamentals — Google Business Profile strength, review generation, treatment-specific content, AI visibility — work the same way. What differs is the regulatory layer around what you can say and show, not the underlying strategy.